VANGL1 and colorectal carcinoma: The presence of an unconventional EGFR‐independent signal of EGF, the KITENIN/ErbB4‐Dvl2‐c‐Jun axis, also mediates increased CRC cell invasiveness and represents poor responses to cetuximab.21, 22